Gene · 134
Papers2,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy. | J Immunother | 2022 | 34510106 | PubTator, text mining | PubMed |
| PFOA regulate adenosine receptors and downstream concentration-response cAMP-PKA pathway revealed by integrated omics and molecular dynamics analyses. | Sci Total Environ | 2022 | 34500266 | PubTator, text mining | PubMed |
| Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms. | Curr Cardiol Rev | 2022 | 34488616 | PubTator, text mining | PubMed |
| Genetic variations of adenosine kinase as predictable biomarkers of efficacy of vagus nerve stimulation in patients with pharmacoresistant epilepsy. | J Neurosurg | 2022 | 34479194 | PubTator, text mining | PubMed |
| Metabolic checkpoints and novel approaches for immunotherapy against cancer. | Int J Cancer | 2022 | 34460110 | PubTator, text mining | PubMed |
| Ethyl 2-amino-4-methyl-thio-phene-3-carboxyl-ate. | IUCrdata | 2021 | 36339105 | PubTator, text mining | PubMed |
| Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics. | RSC Adv | 2021 | 35492478 | PubTator, text mining | PubMed |
| 2-Amino-3,5-dicarbonitrile-6-sulfanylpyridines: synthesis and multiple biological activity - a review. | RSC Adv | 2021 | 35423618 | PubTator, text mining | PubMed |
| Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma? | Front Allergy | 2021 | 35386996 | PubTator, text mining | PubMed |
| Caffeine Therapy for Apnea of Prematurity: Role of the Circadian CLOCK Gene Polymorphism. | Front Pharmacol | 2021 | 35145399 | PubTator, text mining | PubMed |
| Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies. | Front Pharmacol | 2021 | 35140610 | PubTator, text mining | PubMed |
| Caffeine Protects Against Retinal Inflammation. | Front Pharmacol | 2021 | 35069225 | PubTator, text mining | PubMed |
| G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer's disease. | Mol Biomed | 2021 | 35006431 | PubTator, text mining | PubMed |
| Lipids and Phosphorylation Conjointly Modulate Complex Formation of β2-Adrenergic Receptor and β-arrestin2. | Front Cell Dev Biol | 2021 | 35004696 | PubTator, text mining | PubMed |
| Mendelian Randomization Integrating GWAS, eQTL, and mQTL Data Identified Genes Pleiotropically Associated With Atrial Fibrillation. | Front Cardiovasc Med | 2021 | 34977172 | PubTator, text mining | PubMed |
| Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment. | Front Cardiovasc Med | 2021 | 34970606 | PubTator, text mining | PubMed |
| Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance. | Int J Mol Sci | 2021 | 34948316 | PubTator, text mining | PubMed |
| Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. | Int J Mol Sci | 2021 | 34948113 | PubTator, text mining | PubMed |
| Soluble Factors and Receptors Involved in Skin Innate Immunity-What Do We Know So Far? | Biomedicines | 2021 | 34944611 | PubTator, text mining | PubMed |
| RETRACTED: Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A1 Receptor Ligands. | Cells | 2021 | 34944069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134/papers?page=24